4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000038
Chief Scientific Officer sold 2,550 shares at an average $16.78 ($42,783)
From the SEC's structured data for this filing
Trades in this filing
Jewell Christopher M · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-03 | Sale : show line 1 in the form | −1,264 | $16.72 | $21,136 | 54,776 | D |
| 2025-01-06 | Sale : show line 2 in the form | −1,286 | $16.83 | $21,646 | 53,490 | D |
| Open-market sales · 2,550 sh · avg $16.78 · $42,783 | ||||||
Loading xslF345X05/wk-form4_1736298315.xml…